Mitral valve disease is a condition that affects the mitral valve, causing blood to leak backward or flow too slowly, and can ...

Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR). However, very few studies have explored its clinical characteristics, determinants, and ...

Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug ...

Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the need to understand its prognostic factors. Tricuspid regurgitation (TR) is ...

In a medical breakthrough, Duke Health in Durham used parts of a donated heart from one girl to help save two others. Now, ...

Yale operates first the BATMAN procedure in CT, a less invasive heart treatment offering faster recovery and new hope for ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Capstan Medical’s robot platform has been used for the first in-human robotic assisted transcatheter mitral valve replacement ...

In a groundbreaking series of surgeries, doctors at Duke Health have successfully performed the world's first living mitral ...

Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND� Trans-Septal System for ...